MRI and PACS Expansion Radsource is expanding its ProtonPACS offering to hospitals, imaging centers, and physician practices, presenting a clear cross-sell opportunity for integrated radiology workflow optimization and profitability tools.

Leadership and Strategy New CEO Des Varady joined in mid-2024, signaling a potential shift toward growth, partnerships, and teleradiology expansion which could open doors for enterprise-level deals and channel partnerships.

Private Equity Interest HealthEdge Investment Partners partnered with Radsource in early 2024, indicating strong investor backing and potential for scalable deployments, favorable terms for large multi-site customers, and accelerated sales cycles.

Digital Transformation Radsource migrated marketing and support infrastructure to a new hosting provider and redesigned the website in 2023–2024, highlighting readiness for marketing automation, lead generation, and robust customer self-service capabilities.

Mid-market Focus With 51-200 employees and a revenue range of 25 to 50 million, Radsource sits in the mid-market tier where attending regional health systems and imaging networks with ProtonPACS and radiology workflow tools could yield high-value, repeatable deals.